However, further studies will be required to determine if alterations in Rap1 or Rap2 signaling underlie anxiety or depression, how additional Rap GEFS or GAPs influence the development of these phenotypes, and which downstream effectors may be involved. The gene discussed is LRPAP1; the disease is depressive symptom measurement.